GE HealthCare Technologies (GEHC) Barclays 28th Annual Global Healthcare Conference summary

Business exposure and operational resilience

• Middle East exposure is less than 5% of overall business, with a primary focus on employee safety and business continuity amid regional disruptions.

• Manufacturing in Israel supplies global markets, with contingency plans for inventory and logistics outside conflict zones.

• Supply chain agility and dual sourcing are emphasized, building on lessons from COVID and tariff experiences.

Impact of oil prices and tariffs

• Oil price increases mainly affect logistics costs, not raw materials, due to low resin use in products.

• Productivity initiatives and pricing strategies are in place to offset potential cost increases from oil or energy shocks.

• Tariff expenses dropped from $1 billion to $250 million through mitigation efforts, with further reductions expected this year.

• Recent tariff changes (IEEPA replaced by Section 122) are expected to have similar financial impacts, with ongoing monitoring of timing and refunds.

Competitive landscape and product strategy

• New generic competition in contrast agents is anticipated, but supply consistency, quality, and broad portfolio are seen as key differentiators.

• Demand for contrast products remains strong, with tight supply supporting growth opportunities.